Literature DB >> 7712655

Muir-Torre syndrome.

P R Cohen1, S R Kohn, D A Davis, R Kurzrock.   

Abstract

The Muir-Torre syndrome is an autosomal dominantly inherited genodermatosis with malignant potential that is characterized by the presence of at least one sebaceous gland tumor (adenoma, epithelioma, or carcinoma) and a minimum of one internal malignancy. The syndrome has been documented in 147 individuals. Associated features in some of the Muir-Torre syndrome patients are colorectal carcinomas and genitourinary neoplasms. More than half of the 292 visceral cancers described in Muir-Torre syndrome patients were colorectal carcinomas; nearly 60% of these tumors were located at or proximal to the splenic flexure. The presence of even a single Muir-Torre syndrome-associated sebaceous tumor warrants serious consideration for further evaluation of that individual for the syndrome. Therefore, initial and periodic examination for internal malignancy should be performed in individuals with such tumors and patients with the syndrome. Also, family members of Muir-Torre syndrome patients should be screened for Muir-Torre syndrome-associated cutaneous lesions and visceral cancers.

Entities:  

Mesh:

Year:  1995        PMID: 7712655

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  12 in total

1.  Muir-torre syndrome: a case report.

Authors:  Heather J Higgins; Melissa Voutsalath; Jean M Holland
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

Review 2.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

3.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

4.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

5.  Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.

Authors:  N Leonard; R Chaggar; C Jones; M Takahashi; A Nikitopoulou; S R Lakhani
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 6.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

Review 7.  Paraneoplastic dermatological manifestation of gastrointestinal malignancies.

Authors:  Lyubomir A Dourmishev; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

8.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Authors:  Graça M Dores; Rochelle E Curtis; Jorge R Toro; Susan S Devesa; Joseph F Fraumeni
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

9.  Sebaceous carcinoma of the skin of the breast: a case report.

Authors:  Ahmed Alzaraa; Imran Ghafoor; Andrew Yates; Alhad Dhebri
Journal:  J Med Case Rep       Date:  2008-08-15

10.  Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature.

Authors:  K Tsalis; K Blouhos; K Vasiliadis; T Tsachalis; S Angelopoulos; D Betsis
Journal:  World J Surg Oncol       Date:  2006-02-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.